Add BrightSurf on Google Email

Kumamoto University


Reducing the radioresistance of cancer

Researchers at Kumamoto University find that interleukin-6 (IL-6) helps cancer cells survive radiation therapy by suppressing oxidative stress through the Nrf2-antioxidant pathway. This discovery offers new potential therapies targeting IL-6 to combat radioresistant cancers.

SourceKumamoto University·JournalBritish Journal of Cancer·DateJan 13, 2017

Intestinal flora effects drug response

Changes in intestinal flora caused by antibacterial drugs can reduce enzyme activity in the liver and kidneys, affecting drug metabolism and transport. This study suggests that altered intestinal flora may lead to reduced drug efficacy and increased side effects.

SourceKumamoto University·JournalMolecular Pharmaceutics·DateAug 12, 2016

Development of a novel carbon nanomaterial 'pot'

Researchers at Kumamoto University have developed a novel, pot-shaped carbon nanomaterial with a deeper orifice than any previously produced hollow carbon nanostructure. The material's unique characteristic enables it to gradually release substances contained within, making it suitable for applications such as drug delivery systems.

SourceKumamoto University·JournalJournal of Materials Research·DateAug 4, 2016

Molecular switch for controlling color and fluorescence

Researchers at Kumamoto University discovered a new method for drastically changing the color and fluorescence of a compound using oxygen and hydrogen gases. The technique uses energy from gases themselves, producing only water as a byproduct and has potential applications in detection sensors and organic semiconductors.

SourceKumamoto University·JournalAngewandte Chemie International Edition·DateJul 14, 2016

Hidden moss chloroplast 'wall' discovered

Researchers visualize peptidoglycan 'wall' in moss chloroplasts for the first time, overturning traditional understanding of chloroplast structure. The discovery has significant implications for our knowledge of plant cell biology and the origins of photosynthesis.

SourceKumamoto University·JournalThe Plant Cell·DateJul 13, 2016

Finding the right antithrombotic (anti-clotting) drug for you

Researchers from Kumamoto University used a new analysis system to evaluate the effectiveness of antithrombotic drugs in preventing and curing diseases caused by blood clots. The T-TAS system was able to accurately measure blood clotting ability, enabling healthcare providers to make informed decisions about medication management.

SourceKumamoto University·JournalInternational Journal of Cardiology·DateJan 28, 2016

Control of blood vessel formation

Researchers from Kumamoto University and The University of Tokyo have elucidated the control of cellular movement during blood vessel formation, showing that tip cells and trailing cells move at different speeds and directions. This study provides new insights into the complex cellular motion involved in blood vessel proliferation.

SourceKumamoto University·JournalCell Reports·DateNov 19, 2015

Skin cancer-causing fusion gene identified

A novel fusion gene NUP160-SLC43A3 has been identified in skin cancer cells, leading to rapid tumor progression and a significantly shorter duration between symptoms onset and hospital visit. This discovery has potential implications for new diagnostic and therapeutic approaches for angiosarcoma.

SourceKumamoto University·JournalCancer Research·DateNov 1, 2015

The successful ovulation of 100 eggs from 1 female mouse

Researchers developed an ultra-superovulation method to increase the number of eggs obtained from genetically modified mice, reducing the need for multiple females and improving efficiency in IVF and embryo transfers. The breakthrough could lead to a significant reduction in the number of experimental animals used in research.

SourceKumamoto University·JournalPLOS ONE·DateJun 19, 2015

Therapy-resistant breast cancer mechanism revealed

A study published in Nature Communications reveals that a specific type of non-coding RNA, known as Eleanors, plays a key role in the development of endocrine therapy resistance in ER-positive breast cancer cells. Resveratrol was found to repress these RNAs, inhibiting the proliferation of resistant cancer cells.

SourceKumamoto University·JournalNature Communications·DateMay 26, 2015